SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Anixa reports stable disease after 90 days in ovarian cancer CAR-T study

Anixa reported stable disease after 90 days in a patient participating in its CAR-T study for ovarian cancer.

ANIX

Related stories